No Data
No Data
No Data
No Data
No Data
Wandong Medical (600055.SH) announced first-quarter results, net profit of 33.26 million yuan, up 9.26% year on year
According to the Zhitong Finance App, Wandong Medical (600055.SH) disclosed its report for the first quarter of 2024. During the reporting period, the company achieved revenue of 308 million yuan, an increase of 20.94% year on year; net profit to mother was 33.26 million yuan, up 9.26% year on year; after deducting non-net profit of 31.35 million yuan, an increase of 7.06% year on year. Basic earnings per share were $0.04.
Zhitong FinanceApr 26 12:43 ET
Wandong Medical (600055.SH): Net profit increased 7.51% year-on-year in 2023, and plans to distribute 10 to 1.30 yuan
On March 22, Ge Longhui (600055.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 1,237 billion yuan, an increase of 10.30%; net profit attributable to shareholders of listed companies was 189 million yuan, up 7.51% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 136 million yuan, down 13.32% year on year; and basic earnings per share were 0.269 yuan. The 2023 profit distribution plan is based on a total share capital of 703,061,058 shares, with a cash dividend of 1.30 yuan (tax included) for every 10 shares.
Gelonghui FinanceMar 22 06:46 ET
Wandong Medical (600055.SH): There are no plans to develop CT tubes or CT generators
Gelonghui, January 16丨Wandong Medical (600055.SH) said on an interactive platform that currently the company is involved in imported components of CT systems such as CT tubes, CT generators, etc., and the company has no plans to develop CT tubes or CT generators.
Gelonghui FinanceJan 16 03:56 ET
Wandong Medical (600055.SH): Currently developing advanced clinical functions of magnetic resonance according to the plan
Gelonghui, January 16丨Wandong Medical (600055.SH) said on an interactive platform that the company is currently developing advanced clinical functions of magnetic resonance according to the plan.
Gelonghui FinanceJan 16 03:52 ET
Wandong Medical (600055.SH): Currently no 128-row CT has been developed
Gelonghui, December 27丨Wandong Medical (600055.SH) said on an interactive platform that the 3.0T and suspension DSA are being developed according to the plan and will be announced promptly after the registration certificate is officially obtained; the company is not currently developing a 128-row CT.
Gelonghui FinanceDec 27, 2023 04:30 ET
Wandong Healthcare (600055.SH) appoints Song Jinsong as president
Wandong Medical (600055.SH) issued an announcement. The company's board of directors recently received Xie Yufeng, the company's director and president...
Zhitong FinanceDec 8, 2023 03:10 ET
No Data
No Data